14,17(ALPHA)-ETHENO- UND ETHANOESTRATRIENE, VERFAHREN ZUR HERSTELLUNG DIESER VERBINDUNGEN, SOWIE IHRE VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
14,17 alpha -etheno- and ethanooestratrienes of the general formula I in which X is a -CH2-CH2- or bridge, R is a hydrogen atom, a C1-C15-acyl, benzoyl, C1-C15-alkyl, C3-C9-cycloalkyl or alkylcycloalkyl group and R is the group where R and R are, independently of one another, a hydrogen atom or...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 14,17 alpha -etheno- and ethanooestratrienes of the general formula I
in which
X is a -CH2-CH2- or
bridge,
R is a hydrogen atom, a C1-C15-acyl, benzoyl, C1-C15-alkyl, C3-C9-cycloalkyl or alkylcycloalkyl group and
R is the group
where R and R are, independently of one another, a hydrogen atom or a straight-chain or branched, optionally partially or completely fluorinated C1-C8-alkyl group, a process for the preparation thereof, pharmaceutical products containing these compounds, and the use thereof for producing pharmaceuticals, are described.
The compounds have potent antioestrogenic activity. |
---|